News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
736,642 Results
Type
Article (44379)
Company Profile (267)
Press Release (691981)
Multimedia
Podcasts (93)
Webinars (20)
Section
Business (206585)
Career Advice (2235)
Deals (35804)
Drug Delivery (128)
Drug Development (82638)
Employer Resources (177)
FDA (16746)
Job Trends (15120)
News (350321)
Policy (33236)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2713)
Accelerated approval (42)
Adcomms (29)
Allergies (164)
Alliances (50467)
ALS (194)
Alzheimer's disease (1784)
Antibody-drug conjugate (ADC) (377)
Approvals (17039)
Artificial intelligence (615)
Autoimmune disease (231)
Automation (50)
Bankruptcy (365)
Best Places to Work (11747)
BIOSECURE Act (20)
Biosimilars (203)
Biotechnology (176)
Bladder cancer (179)
Brain cancer (66)
Breast cancer (701)
Cancer (5410)
Cardiovascular disease (453)
Career advice (1891)
Career pathing (41)
CAR-T (310)
CDC (58)
Celiac Disease (2)
Cell therapy (824)
Cervical cancer (42)
Clinical research (70980)
Collaboration (1941)
Company closure (4)
Compensation (1270)
Complete response letters (76)
COVID-19 (2794)
CRISPR (102)
C-suite (976)
Cystic fibrosis (150)
Data (7103)
Decentralized trials (3)
Denatured (28)
Depression (160)
Dermatology (57)
Diabetes (552)
Diagnostics (6924)
Digital health (52)
Diversity (12)
Diversity, equity & inclusion (46)
Drug discovery (301)
Drug pricing (202)
Drug shortages (32)
Duchenne muscular dystrophy (269)
Earnings (91226)
Editorial (61)
Employer branding (21)
Employer resources (156)
Events (119363)
Executive appointments (1036)
FDA (20185)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (29)
Funding (1630)
Gene editing (218)
Generative AI (53)
Gene therapy (668)
GLP-1 (1052)
Government (4799)
Grass and pollen (7)
Guidances (396)
Healthcare (19201)
HIV (74)
Huntington's disease (54)
IgA nephropathy (93)
Immunology and inflammation (286)
Immuno-oncology (84)
Indications (157)
Infectious disease (3110)
Inflammatory bowel disease (206)
Inflation Reduction Act (14)
Influenza (129)
Intellectual property (277)
Interviews (365)
IPO (16730)
IRA (51)
Job creations (3691)
Job search strategy (1567)
JPM (61)
Kidney cancer (19)
Labor market (92)
Layoffs (568)
Leadership (36)
Legal (8051)
Liver cancer (100)
Longevity (28)
Lung cancer (731)
Lymphoma (408)
Machine learning (53)
Management (61)
Manufacturing (930)
MASH (181)
Medical device (13994)
Medtech (14072)
Mergers & acquisitions (20222)
Metabolic disorders (1439)
mRNA (185)
Multiple sclerosis (175)
NASH (17)
Neurodegenerative disease (391)
Neuropsychiatric disorders (100)
Neuroscience (3201)
Neurotech (1)
NextGen: Class of 2026 (6673)
Non-profit (4602)
Now hiring (73)
Obesity (681)
Opinion (294)
Ovarian cancer (186)
Pain (231)
Pancreatic cancer (258)
Parkinson's disease (342)
Partnered (33)
Patents (563)
Patient recruitment (596)
Peanut (62)
People (59676)
Pharmaceutical (60)
Pharmacy benefit managers (33)
Phase 1 (22204)
Phase 2 (31229)
Phase 3 (23240)
Pipeline (7145)
Policy (313)
Postmarket research (2587)
Preclinical (9562)
Press Release (67)
Prostate cancer (280)
Psychedelics (50)
Radiopharmaceuticals (309)
Rare diseases (1017)
Real estate (6028)
Recruiting (72)
Regulatory (25343)
Reports (54)
Research institute (2508)
Resumes & cover letters (391)
Rett syndrome (32)
RNA editing (18)
RSV (88)
Schizophrenia (168)
Series A (273)
Series B (204)
Service/supplier (11)
Sickle cell disease (108)
Special edition (22)
Spinal muscular atrophy (169)
Sponsored (46)
Startups (3717)
State (2)
Stomach cancer (19)
Supply chain (120)
Tariffs (92)
The Weekly (62)
Vaccines (1094)
Venture capital (102)
Weight loss (438)
Women's health (110)
Worklife (20)
Date
Last 7 days (639)
Last 30 days (2543)
Last 365 days (30190)
2026 (8055)
2025 (30511)
2024 (35597)
2023 (40482)
2022 (51672)
2021 (56221)
2020 (54714)
2019 (47279)
2018 (35593)
2017 (32649)
2016 (32085)
2015 (38141)
2014 (31788)
2013 (26914)
2012 (29100)
2011 (29779)
2010 (27747)
Location
Africa (773)
Alabama (90)
Alaska (7)
Arizona (331)
Arkansas (13)
Asia (40203)
Australia (6637)
California (12288)
Canada (3517)
China (1243)
Colorado (526)
Connecticut (523)
Delaware (368)
Europe (87907)
Florida (1854)
Georgia (396)
Hawaii (3)
Idaho (62)
Illinois (960)
India (80)
Indiana (562)
Iowa (22)
Japan (488)
Kansas (132)
Kentucky (45)
Louisiana (39)
Maine (73)
Maryland (1488)
Massachusetts (8815)
Michigan (347)
Minnesota (682)
Mississippi (6)
Missouri (140)
Montana (34)
Nebraska (29)
Nevada (135)
New Hampshire (82)
New Jersey (3276)
New Mexico (29)
New York (3247)
North Carolina (1563)
North Dakota (9)
Northern California (6071)
Ohio (370)
Oklahoma (22)
Oregon (41)
Pennsylvania (2502)
Puerto Rico (26)
Rhode Island (50)
South America (1147)
South Carolina (76)
South Dakota (1)
Southern California (4826)
Tennessee (199)
Texas (1936)
United States (43618)
Utah (368)
Vermont (1)
Virginia (293)
Washington D.C. (81)
Washington State (987)
West Virginia (4)
Wisconsin (121)
Wyoming (2)
736,642 Results for "mouse specifics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Ablexis Reports 33 AlivaMab(R) Mouse-Derived Human Antibodies Now in Clinical Development, Further Validating AlivaMab Mouse Transgenic Platform
March 4, 2026
·
2 min read
Press Releases
CancerVax Reports Successful Initial Mouse Study with Breakthrough Results
March 31, 2026
·
6 min read
Press Releases
Peri Launches First Wearable Device Designed Specifically for Perimenopause
April 2, 2026
·
2 min read
Press Releases
Azalea Therapeutics Highlights Nature Publication Demonstrating In Vivo Site-Specific TRAC-CAR T Cell Engineering
March 18, 2026
·
4 min read
Press Releases
Ablexis Announces Validation and Availability of AlivaMab(R) Mouse-NGX
September 3, 2025
·
1 min read
Press Releases
Taconic Biosciences Acquires TransCure bioServices, Building a Comprehensive Global Platform for Humanized Mouse Translational Research
January 21, 2026
·
4 min read
Press Releases
IBA Launches myQAMatriXXAiR to Advance Patient‑Specific QA in Particle Therapy
March 23, 2026
·
3 min read
Press Releases
FirstGene Study Demonstrates High Analytical Sensitivity and Specificity for Each Component of the Test
February 19, 2026
·
5 min read
Press Releases
Caris Life Sciences Finalizes Achieve 1 Study Results Reinforcing the Superior Sensitivity and Specificity of Caris Detect
April 1, 2026
·
6 min read
Press Releases
Cardiff Oncology to Present Preclinical Data with Highly Specific PLK1 Inhibitor Onvansertib at the 2026 AACR Annual Meeting
March 19, 2026
·
2 min read
1 of 73,665
Next
